About Emphasis Pharma
Emphasis Pharma is a Healthcare company. It operates as a providing quality pharmaceutical products and healthcare solutions with a focus on affordability and consumer satisfaction. Its Indian entity Emphasis Pharma Private Limited reported revenue of ₹3.21 Cr. Emphasis Pharma offers products and services including Quality Medicines and Healthcare Solutions. Its focus areas include Services, Healthcare Solutions, Therapeutic Offerings and Pharmaceuticals.
Company details
Emphasis Pharma is recognized as a provider of quality products and healthcare solutions aimed at making good health and longer life accessible at affordable costs. The companys vision is shaped by the philanthropic ideals of its founders, emphasizing a mission termed Believe in We. Commitments to quality medicines and innovative therapies are maintained to ensure satisfaction for consumers and employees, forming the core of its operations. All rights are reserved by the entity, reflecting a structured approach to healthcare delivery across the country. This dedication continues to underpin the organizations foundation in the industry.
- SectorsHealthcare
- Email••••••••
- Legal Name Emphasis Pharma Pvt. Ltd
- Date of Incorporation 01 Jan, 2014
- Jurisdiction Bhopal, Madhya Pradesh, India
- Annual Revenue₹3.21 Cr
FY 2025 · +25% YoY
- Net Profit₹6.1 Lakh
FY 2025 · 2% margin
- EBITDA₹10 Lakh
FY 2025 · 3% margin
Associated legal entities of Emphasis Pharma
Emphasis Pharma operates through Emphasis Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Emphasis Pharma Private Limited CIN U24233MP2014PTC032055 | Active | 01 Jan 2014 | Bhopal, Madhya Pradesh | ₹3.2 Cr | – | 2 | View details |
Products & Services of Emphasis Pharma
Emphasis Pharma offers a comprehensive portfolio of products and services, including Quality Medicines and Healthcare Solutions.
Quality medicines are provided by Emphasis Pharma for various health needs, ensuring accessibility at affordable costs.
Healthcare solutions are offered by Emphasis Pharma, including innovative therapies aimed at consumer satisfaction.
Board of directors of Emphasis Pharma Private Limited (Emphasis Pharma)
Emphasis Pharma Private Limited is the primary company behind Emphasis Pharma. The board of Emphasis Pharma Private Limited currently have 2 directors; the longest-serving is Abid Khan, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abid Khan DIN 06759856 | Director | 01 Jan 2014 | 12 yrs 9 mo | Emphasis Pharma Private Limited |
| Vinay Maithil DIN 06759859 | Director | 01 Jan 2014 | 12 yrs 9 mo | Emphasis Pharma Private Limited |
Financials of Emphasis Pharma
Figures of Emphasis Pharma Private Limited, the primary company behind Emphasis Pharma, for FY 2025. Revenue was ₹3.21 Cr (+25% year on year). Net profit was ₹6.1 Lakh (2% margin). EBITDA was ₹10 Lakh (3% margin). Revenue has grown at a compounded annual rate of +19% over three years and +20% over five years.
- ₹3.21 CrRevenue · FY 2025 · +25% YoY
- ₹6.1 LakhNet profit · 2% margin
- ₹10 LakhEBITDA · 3% margin
- ₹1 LakhPaid-up capital
- +19%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Emphasis Pharma Private Limited are on its company page.
Detailed financial statements for Emphasis Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Emphasis Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Emphasis Pharma
The primary company behind Emphasis Pharma, Emphasis Pharma Private Limited, reported revenue of ₹3.21 Cr for FY 2025, up 25% year on year.
Emphasis Pharma is recognized as a provider of quality products and healthcare solutions aimed at making good health and longer life accessible at affordable costs. The companys vision is shaped by the philanthropic ideals of its founders, emphasizing a mission termed Believe in We. Commitments to quality medicines and innovative therapies are maintained to ensure satisfaction for consumers and employees, forming the core of its operations. All rights are reserved by the entity, reflecting a structured approach to healthcare delivery across the country. This dedication continues to underpin the organizations foundation in the industry.
Emphasis Pharma offers Quality Medicines and Healthcare Solutions.
Emphasis Pharma operates through Emphasis Pharma Private Limited.
The legal entities of Emphasis Pharma currently have 2 directors, including Abid Khan, Vinay Maithil.